The negative predictive value of FDG PET/CT staging in early oropharyngeal squamous cell carcinoma and implications to transoral robotic surgery patient selection
Autor: | Mario Tapia, Jamil Manji, Kaman Dhillon, Stephen Kleid, Samuel Flatman, Jessica Prasad, Anthony Cardin, Tsien Fua, Danny Rischin, Benjamin Dixon, Matthew J.R Magarey |
---|---|
Rok vydání: | 2022 |
Předmět: |
Adult
Cancer Research Squamous Cell Carcinoma of Head and Neck Patient Selection Oropharyngeal Neoplasms Oncology Robotic Surgical Procedures Fluorodeoxyglucose F18 Predictive Value of Tests Head and Neck Neoplasms Positron Emission Tomography Computed Tomography Carcinoma Squamous Cell Humans Oral Surgery Retrospective Studies Neoplasm Staging |
Zdroj: | Oral oncology. 135 |
ISSN: | 1879-0593 |
Popis: | Our objective was to determine the negative predictive value (NPV) of preoperative FDG PET/CTfor detecting locoregional nodal disease. The aim was to help inform the decision-making process when identifying patients with early-stage OPSCC that would be suitable for transoral robotic surgery (TORS) as a single-modality treatment.A retrospective cohort study was conducted of adults with primary stage cT1-2 OPSCC with up to one metastatic neck lymph node (cN0-1) planned for TORS. Patients with a preoperative PET/CT and who had undergone staging neck dissection (ND) were included. Clinical and pathological nodal staging was established based on PET/CT and ND, respectively. The primary outcome was the frequency of occult (not seen on PET/CT) nodal disease on ND.Eighty-eight patients were included (N = 88). The rate of occult nodal disease was 28.4 % (n = 25). The NPV of PET/CT in the clinically negative neck was 79 % and 66 % in cases with a single clinical node. Following staging ND, thetreatment plan changed in 27 % of cases overall, 7 % in cN0 and 36.7 % in cN1. Among these, 18 % met criteria for radiotherapy and 9 % for CRT. This represented a decrease in the number of ideal candidates for TORS as single-modality treatment from 88 to 64 (73 %).PET/CT is a useful tool in the workup of patients for primary TORS. However, about one third of patients with early-stage OPSCC might benefit from adjuvant therapy not predicted by preoperative PET/CT. A staging ND helps confirm candidates for single-modality treatment with TORS. |
Databáze: | OpenAIRE |
Externí odkaz: |